Skip to content

SCORE - Sickle cell outreach, resources & engagement

Exploring the design and operation of community health and wellbeing sickle cell hubs (‘sickle hubs’) to relieve pressure on GPs and hospital services

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN17711930
Enrollment
200
Registered
2025-08-12
Start date
2025-10-01
Completion date
Unknown
Last updated
2025-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sickle cell disease Haematological Disorders

Interventions

Delphi reflection cycles on the feasibility of sickle cell community treatment hubs. This is an exploratory study to explore potential functions, operation, feasibility, acceptability and potential m

Sponsors

Liverpool School of Tropical Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. All participants must willfully consent to participate. 2. Adolescents living with SCD 2.1. Aged 15 and older 2.2. Parent/caregiver has provided informed consent 2.3. Adolescent has given assent to participate 3. Carers of people living with SCD 3.1. Aged 18 and older 3.2. Caring for at least one person with SCD 4. SCD healthcare providers 4.1. Aged 18 and older 4.2. Playing a role in supporting clinical management of patients with SCD, including in hospital and GP practices 5. Stakeholders with potential to input to the functioning of hubs 5.1. Aged 18 and older 5.2. Representatives from social services, Citizens Advice and councils 5.3. Academics (including clinical educators) 6. Working with community-based or non-governmental organisations that support people living with SCD and their families

Exclusion criteria

Exclusion criteria: Not meeting the key inclusion criteria.

Design outcomes

Primary

MeasureTime frame
A 'test-ready' scalable intervention, in the form of community sickle cell disease hubs, with recommendations for potential locations and evaluation metrics ready to be trialled in a subsequent study. This will be developed from research outputs, including a scoping review [at month 5]; a cohort of trained and experienced community research champions with shareable training resources relevant for sickle cell disease [at month 6]; and a collaboratively refined theory of change [at month 14], to underpin future testing of the hubs developed from the Delphi framework.

Secondary

MeasureTime frame
There are no secondary outcome measures

Countries

England, United Kingdom

Contacts

Public ContactSusie Crossman
susie.crossman@lstmed.ac.uk+44 (0)1517052564

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026